Upregulation of cytokines and IL-17 in patients with hereditary angioedema

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 5, 2014, Pages

  Arcoleo, Francesco ^a   Salemi, Marilisa ^a   La Porta, Antonio ^a   Selvaggio, Valentina ^b   Mandalà, Vitalba ^c   Muggeo, Vito ^c   Misiano, Gabriella ^c   Milano, Salvatore ^c   Romano, Giuseppina Colonna ^c   Cillari, Enrico ^a  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b Tempor Agengy   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

cytokines; hereditary angioedema; IL 17; Th 17

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; CYTOKINE; INTERLEUKIN 17;

ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; CHILD; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; UPREGULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANGIOEDEMAS, HEREDITARY; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; MUTATION; UP-REGULATION; YOUNG ADULT;

EID: 84898964317     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-1008     Document Type: Letter

References (10)

1. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992;71:206-15.
2. Cicardi M, Banerjo A, Bracho F, Malbràn A, Rosenkranz B, Riedl M, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010;363:532-41.
3. Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, et al. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Clin Exp Allergy 2012;42:929-35.
4. Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003;3:311-7. (Pubitemid 36293959)
5. Cillari E, Misiano G, Aricò M, La Rocca E, Lio D, Di Leonardo S, et al. Modification of peripheral blood T-lymphocyte surface receptors and Langerhans cell numbers in hereditary angioedema. Am J Clin Pathol 1986;85:305-11. (Pubitemid 16071216)
6. Prada AE, Zahedi K, Davis AE 3rd. Regulation of C1 inhibitor synthesis [review]. Immunobiology 1998;199:377-88.
7. Gluszko P, Undas A, Amenta S, Szczeklik A, Schmaier AH. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor. J Lab Clin Med 1994;123:232-40. (Pubitemid 2055725)
8. West B, Welch K, Galecki A. Linear mixed models: a practical guide using statistical software. London: Chapman & Hall/CRC, 2007:21-9.
9. Coelho dos Santos JS, Menezes CA, Villani FN, Magalhães LM, Scharfstein J, Gollob KJ, et al. Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells. Clin Exp Immunol 2010; 162: 528-36.
10. Platten M, Youssef S, Hur EM, Ho PP, Han MH, Lanz TV, et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1-and TH17 mediated autoimmunity. Proc Natl Acad Sci USA 2009;106:14948-53.